Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × Pregabalin × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 3 Neuralgia 3 Breast Neoplasms 3 Seizures 1 Pinealoma 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Myotoxicity 1 Meningioma 1 Medulloblastoma 1 Lymphoma 1 Inflammation 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Earache 1 Drug-Related Side Effects and Adverse Reactions 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Agnosia 1

Interventions

Cisplatin 113 Radiotherapy 71 Cetuximab 68 Docetaxel 50 Paclitaxel 41 pembrolizumab 39 Carboplatin 39 Fluorouracil 38 Radiotherapy, Intensity-Modulated 30 Drug Therapy 15 Radiation 13 Gefitinib 13 Nivolumab 11 Gemcitabine 11 Surgical Procedures, Operative 10 Bevacizumab 10 Amifostine 9 tislelizumab 8 Pemetrexed 8 Oxaliplatin 8 Erlotinib Hydrochloride 8 Celecoxib 8 Capecitabine 8 durvalumab 7 atezolizumab 7 Filgrastim 7 Panitumumab 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06766916 2025-05-18

CRYSTAL

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting

Head and Neck Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡